Exo Releases FDA-Cleared AI Apps for Heart and Lung Diagnosis
Medical imaging software company Exo announces the availability of its U.S. FDA-cleared cardiac and lung AI applications on Exo Iris, its handheld ultrasound device.
Medical imaging software company Exo announces the availability of its U.S. FDA-cleared cardiac and lung AI applications on Exo Iris, its handheld ultrasound device.
Royal Philips has unveiled the Philips CT 5300 system, featuring artificial intelligence (AI) capabilities tailored for diagnosis, interventional procedures, and screening.
Japanese researchers have made a significant breakthrough by developing an AI model that uses CT and MRI images to predict lymph node metastasis in nonfunctional pancreatic neuroendocrine tumors.
Using a routine chest X-ray image, an artificial intelligence tool can identify non-smokers who are at high risk for lung cancer, according to a study being presented at the annual meeting of the Radiological Society of North America.
Read MoreKorea’s Lunit has secured U.S. FDA clearance for its 3D breast tomosynthesis AI solution, Lunit Insight DBT, enabling its entry into the U.S. breast screening market.
Read MoreThe University of Miami Health System is partnering with Aidoc for a system-wide artificial intelligence initiative that aims to detect early health issues, streamline workflows, and enhance post-diagnosis care using Aidoc’s AI technology.
Read MoreExplore pivotal strategies for cloud migration tailored to enhance medical imaging. This Frost & Sullivan white paper provides a roadmap for immediate ROI and long-term success for healthcare leaders.
Read MoreSirona Medical, a cloud-native radiology workflow software provider, now offers support for SpaceX’s Starlink platform, allowing users to access its high-performance services from virtually anywhere in the world.
Read More